Offer - Urjas Oil for just ₹ 1 X
Polypod CV 200 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Polypod CV 200 Tablet (10) have also been explained below.
The correct dosage of Polypod CV 200 Tablet (10) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Polypod CV 200 Tablet (10) can also lead to other problems, which have been listed below. Such side effects of Polypod CV 200 Tablet (10) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Polypod CV 200 Tablet (10)'s effect during pregnancy is Mild and Moderate while nursing. In addition, Polypod CV 200 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Polypod CV 200 Tablet (10) related warnings section.
Polypod CV 200 Tablet (10) is contraindicated in people with pre-existing medical conditions like Jaundice as it can result in adverse effects. The section on Polypod CV 200 Tablet (10) contraindications lists all such conditions.
Besides this, Polypod CV 200 Tablet (10) may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Polypod CV 200 Tablet (10) is safe while driving, and is addiction.
Polypod CV 200 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Polypod CV 200 Tablet (10) safe for pregnant women?
Polypod CV has little to no side effects in pregnant women.
Is the use of Polypod CV 200 Tablet (10) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Polypod CV. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Polypod CV 200 Tablet (10) on the Kidneys?
There can be some harmful effects on your kidneys after taking Polypod CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Polypod CV 200 Tablet (10) on the Liver?
You may experience side effects on your liver after taking Polypod CV. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Polypod CV 200 Tablet (10) on the Heart?
Polypod CV is rarely harmful for the heart.
Polypod CV 200 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Polypod CV 200 Tablet (10) unless your doctor advises you to do so -
Is this Polypod CV 200 Tablet (10) habit forming or addictive?
No, you will not get addicted to Polypod CV 200 Tablet (10).
Interaction between Food and Polypod CV 200 Tablet (10)
Taking Polypod CV 200 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Polypod CV 200 Tablet (10)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Polypod CV 200 Tablet (10).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311